Administration of Basal Insulin 10 Units
Basal insulin at 10 units should be administered as a single subcutaneous injection once daily, either at bedtime (for NPH insulin) or at any consistent time of day (for long-acting basal analogs like glargine or detemir). 1
Initial Dosing and Timing
The standard starting dose for basal insulin is 10 units per day OR 0.1-0.2 units/kg per day, whichever is appropriate for the patient's weight and clinical situation. 1
Timing Options:
- NPH insulin: Administer at bedtime 1
- Long-acting basal analogs (glargine 100 U/mL, glargine 300 U/mL, detemir, degludec): Can be administered at any consistent time of day, though bedtime is commonly used 1
- Special consideration: NPH can be dosed in the morning for steroid-induced hyperglycemia 1
Titration Protocol
After initiating at 10 units, systematic titration is essential to achieve fasting plasma glucose (FPG) goals without causing hypoglycemia. 1
Evidence-Based Titration Algorithm:
- Set individualized FPG goal (typically 80-130 mg/dL or 4.4-7.2 mmol/L) 1, 2
- Increase by 2 units every 3 days until FPG goal is reached without hypoglycemia 1
- Alternative approach: Increase by 1 unit per day (for NPH, detemir, glargine 100 U/mL) or 2-4 units once or twice per week (for all basal insulins including glargine 300 U/mL and degludec) 2
Hypoglycemia Management:
- If hypoglycemia occurs: Determine the cause; if no clear reason identified, lower the dose by 10-20% 1
Important Clinical Considerations
Patient Education Requirements:
- Patients require education on blood glucose self-monitoring, proper injection technique, recognizing and responding to hypoglycemia, and maintaining healthy diet and exercise 3
- Glucagon should be prescribed for emergent hypoglycemia when initiating basal insulin 1
Monitoring and Assessment:
- Assess insulin dose adequacy at every visit 1
- Watch for signs of overbasalization: elevated bedtime-to-morning glucose differential, hypoglycemia (aware or unaware), or high glucose variability 1
- Doses can be increased up to approximately 0.5-1.0 units/kg/day in some cases, but continuing to escalate without meaningful FPG reduction is not recommended 2
Expected Outcomes:
- HbA1c reductions of -1.5% to -2.5% are achievable 3
- Approximately 50% of patients can achieve HbA1c <7% with insulin doses around 40-70 units/day 3
- Potential weight gain of approximately 3 kg over 6 months 3
Common Pitfalls to Avoid
Do not continue escalating basal insulin doses indefinitely without achieving FPG goals—this represents overbasalization and requires re-evaluation of the overall treatment strategy, potentially adding GLP-1 receptor agonists or prandial insulin. 1, 2
Ensure consistent timing of insulin administration, as adherence to a regular schedule is critical for achieving stable glycemic control. 1